Mission COVID Suraksha

New Delhi: The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID…

New Delhi: Zydus Cadila has received approval for Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D today, the world’s first and India’s indigenously developed DNA based vaccine for COVID-19 to…

New Delhi: Bharat Biotech's intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2 trials. This is the first of its kind COVID-19 jab to undergo human clinical trials in India. BBV154 is an…

New Delhi: Minister for Chemicals & Fertilizers D.V. Sadananda Gowda visited Bharat Biotech, Hyderabad on Sunday to oversee the Covaxin production. Minister interacted with the top scientists of Bharat Biotech and complemented the…

Hyderabad: In a bid to augment the vaccine production, the Government has decided to support some public sector companies with grants under the Mission COVID Suraksha. One such company is the Hyderabad-based Indian Immunological Limited…